Jiangsu Huaian Mingde Bio-chemical Technology Co., Ltd. has always been dedicated to development of anti-tumor material drug and intermediates, and is a high-tech enterprise which mainly takes producing and selling antineoplastic drugs as priority. The company involves many fields including pharmaceutical materials, pharmaceutical Intermediates, fine chemicals and other fields. The company has their own research and development center and production base. The company has two main products which are antineoplastic and gemcitabine hydrochloride.
We can independently produce gemcitabine hydrochloride and intermediates, and possess own patents, advanced technology and domestic leading cost.
Anti-cancer drug products are developed by Shanghai Pharmaceutical Institute of Chinese Academy of Sciences and Shanghai Organic Instititue, and have domestic leading technology advantages and competitiveness. At present, products include Erlotinib, Dasatinib, Nilotinib, MesylateImatinib, Gefitinib, Sunitinib, Sorafenib, Lapatinib, Malic Acid Sunitinib, Imatinib, MesylateSorafenib, HydrochlorideErlotinib and Intermediates. Now I continue to develop other products to try to bigger in products.
The company has self-import and export rights. More than 90% of products are sold in United States, Europe, South America, India and other countries and regions. The Company has always insisted on the tenet of cooperation if existing orders, and gets satisfaction from customers.
The company hopes that we can continue keeping mutual honest, benefits and stable cooperation relationships depending on high and new technology and high quality products to make a longer development.